The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
African Trypanosomiasis-Global Market Insights and Sales Trends 2024
Synopsis
African Trypanosomiasis, also known as sleeping sickness disease, is one of the rarest infectious diseases that can affect one’s sleep pattern to a great extent. It is a parasitic disease caused by protozoan parasite of genus Trypanosoma and is carried by tsetse fly. There are two types of African Trypanosomiasis depending on the parasite: East African Trypanosomiasis caused by Trypanosoma brucei rhodesiense and West African Trypanosomiasis caused by Trypanosomiasis brucei gambiense.
The global African Trypanosomiasis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of African Trypanosomiasis in various end use industries. The expanding demands from the Blood Samples, Bone Marrow, Lymph Node Fluid and Cerebrospinal Fluid or Lymph Node Aspirate, are propelling African Trypanosomiasis market. Trypanosoma Brucei Rhodesiense, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Trypanosomiasis Brucei Gambiense segment is estimated at % CAGR for the next seven-year period.
According to WHO, 25,000 new cases of both East and West African Trypanosomiasis are reported each year globally. African Trypanosomiasis is primarily found in subtropical and equatorial Africa. The major driving factors for the growth of the African Trypanosomiasis market in this region are constantly growing number of poor population in East African, prevalence of unhygienic environment, rapid pace of technological advancement in the field of African Trypanosomiasis therapeutics, increasing number of population to opt for healthy lifestyle and the overall growing diagnostic and therapeutic market. On the other hand, the huge cost of drugs involved in the treatment of African Trypanosomiasis and difficulty in availability of these medications would most likely impede the growth of this market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for African Trypanosomiasis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global African Trypanosomiasis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global African Trypanosomiasis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, African Trypanosomiasis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of African Trypanosomiasis covered in this report include Sanofi, Genzyme Corporation, aRigen Pharmaceuticals, Immtech Pharmaceuticals and Anacor Pharmaceuticals, etc.
The global African Trypanosomiasis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Genzyme Corporation
aRigen Pharmaceuticals
Immtech Pharmaceuticals
Anacor Pharmaceuticals
Global African Trypanosomiasis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global African Trypanosomiasis market, Segment by Type:
Trypanosoma Brucei Rhodesiense
Trypanosomiasis Brucei Gambiense
Global African Trypanosomiasis market, by Application
Blood Samples
Bone Marrow
Lymph Node Fluid
Cerebrospinal Fluid or Lymph Node Aspirate
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of African Trypanosomiasis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
African Trypanosomiasis, also known as sleeping sickness disease, is one of the rarest infectious diseases that can affect one’s sleep pattern to a great extent. It is a parasitic disease caused by protozoan parasite of genus Trypanosoma and is carried by tsetse fly. There are two types of African Trypanosomiasis depending on the parasite: East African Trypanosomiasis caused by Trypanosoma brucei rhodesiense and West African Trypanosomiasis caused by Trypanosomiasis brucei gambiense.
The global African Trypanosomiasis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of African Trypanosomiasis in various end use industries. The expanding demands from the Blood Samples, Bone Marrow, Lymph Node Fluid and Cerebrospinal Fluid or Lymph Node Aspirate, are propelling African Trypanosomiasis market. Trypanosoma Brucei Rhodesiense, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Trypanosomiasis Brucei Gambiense segment is estimated at % CAGR for the next seven-year period.
According to WHO, 25,000 new cases of both East and West African Trypanosomiasis are reported each year globally. African Trypanosomiasis is primarily found in subtropical and equatorial Africa. The major driving factors for the growth of the African Trypanosomiasis market in this region are constantly growing number of poor population in East African, prevalence of unhygienic environment, rapid pace of technological advancement in the field of African Trypanosomiasis therapeutics, increasing number of population to opt for healthy lifestyle and the overall growing diagnostic and therapeutic market. On the other hand, the huge cost of drugs involved in the treatment of African Trypanosomiasis and difficulty in availability of these medications would most likely impede the growth of this market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for African Trypanosomiasis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global African Trypanosomiasis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global African Trypanosomiasis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, African Trypanosomiasis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of African Trypanosomiasis covered in this report include Sanofi, Genzyme Corporation, aRigen Pharmaceuticals, Immtech Pharmaceuticals and Anacor Pharmaceuticals, etc.
The global African Trypanosomiasis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Genzyme Corporation
aRigen Pharmaceuticals
Immtech Pharmaceuticals
Anacor Pharmaceuticals
Global African Trypanosomiasis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global African Trypanosomiasis market, Segment by Type:
Trypanosoma Brucei Rhodesiense
Trypanosomiasis Brucei Gambiense
Global African Trypanosomiasis market, by Application
Blood Samples
Bone Marrow
Lymph Node Fluid
Cerebrospinal Fluid or Lymph Node Aspirate
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of African Trypanosomiasis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of African Trypanosomiasis
1.1 African Trypanosomiasis Market Overview
1.1.1 African Trypanosomiasis Product Scope
1.1.2 African Trypanosomiasis Market Status and Outlook
1.2 Global African Trypanosomiasis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global African Trypanosomiasis Market Size by Region (2018-2029)
1.4 Global African Trypanosomiasis Historic Market Size by Region (2018-2023)
1.5 Global African Trypanosomiasis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, African Trypanosomiasis Market Size (2018-2029)
1.6.1 North America African Trypanosomiasis Market Size (2018-2029)
1.6.2 Europe African Trypanosomiasis Market Size (2018-2029)
1.6.3 Asia-Pacific African Trypanosomiasis Market Size (2018-2029)
1.6.4 Latin America African Trypanosomiasis Market Size (2018-2029)
1.6.5 Middle East & Africa African Trypanosomiasis Market Size (2018-2029)
2 African Trypanosomiasis Market by Type
2.1 Introduction
2.1.1 Trypanosoma Brucei Rhodesiense
2.1.2 Trypanosomiasis Brucei Gambiense
2.2 Global African Trypanosomiasis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global African Trypanosomiasis Historic Market Size by Type (2018-2023)
2.2.2 Global African Trypanosomiasis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America African Trypanosomiasis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe African Trypanosomiasis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific African Trypanosomiasis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America African Trypanosomiasis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa African Trypanosomiasis Revenue Breakdown by Type (2018-2029)
3 African Trypanosomiasis Market Overview by Application
3.1 Introduction
3.1.1 Blood Samples
3.1.2 Bone Marrow
3.1.3 Lymph Node Fluid
3.1.4 Cerebrospinal Fluid or Lymph Node Aspirate
3.2 Global African Trypanosomiasis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global African Trypanosomiasis Historic Market Size by Application (2018-2023)
3.2.2 Global African Trypanosomiasis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America African Trypanosomiasis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe African Trypanosomiasis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific African Trypanosomiasis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America African Trypanosomiasis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa African Trypanosomiasis Revenue Breakdown by Application (2018-2029)
4 African Trypanosomiasis Competition Analysis by Players
4.1 Global African Trypanosomiasis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in African Trypanosomiasis as of 2022)
4.3 Date of Key Players Enter into African Trypanosomiasis Market
4.4 Global Top Players African Trypanosomiasis Headquarters and Area Served
4.5 Key Players African Trypanosomiasis Product Solution and Service
4.6 Competitive Status
4.6.1 African Trypanosomiasis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi African Trypanosomiasis Products, Services and Solutions
5.1.4 Sanofi African Trypanosomiasis Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Genzyme Corporation
5.2.1 Genzyme Corporation Profile
5.2.2 Genzyme Corporation Main Business
5.2.3 Genzyme Corporation African Trypanosomiasis Products, Services and Solutions
5.2.4 Genzyme Corporation African Trypanosomiasis Revenue (US$ Million) & (2018-2023)
5.2.5 Genzyme Corporation Recent Developments
5.3 aRigen Pharmaceuticals
5.3.1 aRigen Pharmaceuticals Profile
5.3.2 aRigen Pharmaceuticals Main Business
5.3.3 aRigen Pharmaceuticals African Trypanosomiasis Products, Services and Solutions
5.3.4 aRigen Pharmaceuticals African Trypanosomiasis Revenue (US$ Million) & (2018-2023)
5.3.5 Immtech Pharmaceuticals Recent Developments
5.4 Immtech Pharmaceuticals
5.4.1 Immtech Pharmaceuticals Profile
5.4.2 Immtech Pharmaceuticals Main Business
5.4.3 Immtech Pharmaceuticals African Trypanosomiasis Products, Services and Solutions
5.4.4 Immtech Pharmaceuticals African Trypanosomiasis Revenue (US$ Million) & (2018-2023)
5.4.5 Immtech Pharmaceuticals Recent Developments
5.5 Anacor Pharmaceuticals
5.5.1 Anacor Pharmaceuticals Profile
5.5.2 Anacor Pharmaceuticals Main Business
5.5.3 Anacor Pharmaceuticals African Trypanosomiasis Products, Services and Solutions
5.5.4 Anacor Pharmaceuticals African Trypanosomiasis Revenue (US$ Million) & (2018-2023)
5.5.5 Anacor Pharmaceuticals Recent Developments
6 North America
6.1 North America African Trypanosomiasis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe African Trypanosomiasis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific African Trypanosomiasis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America African Trypanosomiasis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa African Trypanosomiasis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 African Trypanosomiasis Market Dynamics
11.1 African Trypanosomiasis Industry Trends
11.2 African Trypanosomiasis Market Drivers
11.3 African Trypanosomiasis Market Challenges
11.4 African Trypanosomiasis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
